Correspondence | Published:

Reply to “KSHV reactivation in post-transplant Kaposi sarcoma”

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Barozzi, P. et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat. Med. 9, 554–561 (2003).

  2. 2

    Parravicini, C. et al. Risk of Kaposi's sarcoma-associated herpesvirus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 90, 2826–2829 (1997).

  3. 3

    Farge, D. et al. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Coopératif de Transplantation d'Ile de France (GCIF). Transplantation 67, 1236–1242 (1999).

  4. 4

    Euvrard, S. et al. Skin cancers after organ transplantation. N. Engl. J. Med. 348, 1681–1691 (2003).

  5. 5

    Luppi, M. et al. Human herpes virus-8 (HHV-8) associated diseases in solid organ transplantation: importance of viral transmission from the donor. Clin. Infect. Dis., in press.

  6. 6

    Luppi, M., et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. New Engl J Med 343, 1378–1385 (2000).

  7. 7

    Luppi, M., et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 96, 3279–3281 (2000).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article